Gain-of-Function Claims for Type-2-Diabetes-Associated Coding Variants in SLC16A11 Are Not Supported by the Experimental Data
Human genetic variants inSLC16A11are associatedwith increased risk of type 2 diabetes (T2D). We pre-viously identified two distinct mechanisms throughwhich co-inherited T2D-risk coding and non-codingvariants disruptSLC16A11expression and activity,thus implicating reduced SLC16A11 function as thedise...
Main Author: | Lander, Eric S. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | English |
Published: |
Elsevier BV
2020
|
Online Access: | https://hdl.handle.net/1721.1/125204 |
Similar Items
-
Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms
by: Rusu, Victor, et al.
Published: (2018) -
The SLC16 monocaboxylate transporter family.
by: Meredith, D, et al.
Published: (2008) -
SLC22A1, SLC22A2, SLC22A3 and 11ßHSD1 gene polymorphisms among Malaysian Indians with type 2 diabetes mellitus
by: Abood, Al Ashoor Sabah Ghasan
Published: (2019) -
Contribution of SLC30A8 variants to the risk of type 2 diabetes in a multi-ethnic population: a case control study
by: Salem, S.D., et al.
Published: (2014) -
Genetic association of SLC2A9 variants with gout susceptibility in Malay population
by: Adanan @ Adnan, Mahfudzah
Published: (2015)